Allergan
Allergan transfers drug patent to Mohawk tribe to sidestep lawsuits
09 Sep 2017
The surprise move by Allergan to transfer the patents on a best-selling eye drug to the Saint Regis Mohawk Tribe could open up a new way for drug makers to head off challenges to patents
Allergan to buy Tobira Therapeutics for $1.7 bn
20 Sep 2016
Allergan to sell US distribution unit Anda to Teva for $500 mn
04 Aug 2016
The sale comes just a day after Teva completed its $40.5-billion acquisition of Allergan’s generic unit, following US regulatory approval a week ago
Pfizer calls halt to $160bn merger with Allergan: report
06 Apr 2016
The decision comes after the US Treasury unveiled new rules that proposed to limit companies’ ability to participate in inversion transactions if they have been engaged in acquisitions within the past 36 months
New Treasury rules threaten Allergan-Pfizer merger
05 Apr 2016
The US Treasury Department has framed new rules to throttle ‘inversions’, in a move seen to be directly prompted by the proposed Allergan-Pfizer merger, which would create the world’s biggest drug firm
